<DOC>
	<DOC>NCT01006486</DOC>
	<brief_summary>A clinical trial designed to compare the oral anticoagulation control obtained by an anticoagulation clinic and the usual medical care in Chagas and Non-Chagas disease patients.</brief_summary>
	<brief_title>Outcomes of an Anticoagulation Clinic in an University Hospital</brief_title>
	<detailed_description>A Randomized, Crossover, Clinical Trial performed to compare the results of oral anticoagulation for Chagas and non-Chagas disease patients treated at an anticoagulation clinic and by the usual clinical practice. The primary endpoint was the time that the International Normalized Ratio (INR) was in the therapeutic range and the secondary endpoints were thromboembolic/haemorragic events.</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Chagas Disease</mesh_term>
	<criteria>Outpatients Chagas and nonChagas disease patients Any indication for chronic treatment with warfarin Anticoagulation for at least 30 days. Refusal to participate in the study; Use of phenprocoumon; Expectation of treatment lower than 1 year; Difficulties to attend medical visits; Participation in other prospective clinical study involving anticoagulation care during the study period.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Oral anticoagulants</keyword>
	<keyword>Warfarin</keyword>
	<keyword>Anticoagulation clinic</keyword>
	<keyword>Thrombosis</keyword>
	<keyword>Hemorrhage</keyword>
</DOC>